-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q1 2024.
- Prime Medicine, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $134K.
- Prime Medicine, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$279K, a 71.1% increase from 2022.
- Prime Medicine, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$964K, a 54.5% decline from 2021.
- Prime Medicine, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$624K, a 133% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)